Management Turnover as Change Agent

Monday, July 23, 2007

Novartis CEO Successor May Have Been Selected

According to an article in the Swiss weekly SonntagsZeitung, picked up by Forbes 7/23/07, Novartis AG NVS (NYSE) chief executive Daniel Vasella might propose current Vaccines & Diagnostics chief executive Joerg Reinhardt as his successor.

No comments: